Global Dengue Virus Diagnostic Tests Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Dengue Virus Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Dengue Virus Diagnostic Tests market size is estimated to be worth US$ 3344.4 million in 2021 and is forecast to a readjusted size of USD 4251.7 million by 2028 with a CAGR of 3.5% during review period. Hospital accounting for % of the Dengue Virus Diagnostic Tests global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dengue NS1Ag Test segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Dengue Virus Diagnostic Tests include Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, and Wondfo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dengue Virus Diagnostic Tests market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test
Market segment by Application, can be divided into
Hospital
Research Institution
Others
Market segment by players, this report covers
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Dengue Virus Diagnostic Tests product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Dengue Virus Diagnostic Tests, with revenue, gross margin and global market share of Dengue Virus Diagnostic Tests from 2019 to 2022.
Chapter 3, the Dengue Virus Diagnostic Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Dengue Virus Diagnostic Tests market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Dengue Virus Diagnostic Tests research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Dengue Virus Diagnostic Tests
1.2 Classification of Dengue Virus Diagnostic Tests by Type
1.2.1 Overview: Global Dengue Virus Diagnostic Tests Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Dengue Virus Diagnostic Tests Revenue Market Share by Type in 2021
1.2.3 Dengue NS1Ag Test
1.2.4 Dengue IgG/IgM Test
1.2.5 Dengue NS1 Ag-IgG/IgM Test
1.3 Global Dengue Virus Diagnostic Tests Market by Application
1.3.1 Overview: Global Dengue Virus Diagnostic Tests Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Research Institution
1.3.4 Others
1.4 Global Dengue Virus Diagnostic Tests Market Size & Forecast
1.5 Global Dengue Virus Diagnostic Tests Market Size and Forecast by Region
1.5.1 Global Dengue Virus Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Dengue Virus Diagnostic Tests Market Size by Region, (2017-2022)
1.5.3 North America Dengue Virus Diagnostic Tests Market Size and Prospect (2017-2028)
1.5.4 Europe Dengue Virus Diagnostic Tests Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Dengue Virus Diagnostic Tests Market Size and Prospect (2017-2028)
1.5.6 South America Dengue Virus Diagnostic Tests Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Dengue Virus Diagnostic Tests Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Dengue Virus Diagnostic Tests Market Drivers
1.6.2 Dengue Virus Diagnostic Tests Market Restraints
1.6.3 Dengue Virus Diagnostic Tests Trends Analysis
2 Company Profiles
2.1 Alere
2.1.1 Alere Details
2.1.2 Alere Major Business
2.1.3 Alere Dengue Virus Diagnostic Tests Product and Solutions
2.1.4 Alere Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Alere Recent Developments and Future Plans
2.2 Biogate
2.2.1 Biogate Details
2.2.2 Biogate Major Business
2.2.3 Biogate Dengue Virus Diagnostic Tests Product and Solutions
2.2.4 Biogate Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Biogate Recent Developments and Future Plans
2.3 NovaBios Laboratories Diagnostics
2.3.1 NovaBios Laboratories Diagnostics Details
2.3.2 NovaBios Laboratories Diagnostics Major Business
2.3.3 NovaBios Laboratories Diagnostics Dengue Virus Diagnostic Tests Product and Solutions
2.3.4 NovaBios Laboratories Diagnostics Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 NovaBios Laboratories Diagnostics Recent Developments and Future Plans
2.4 Rapikit
2.4.1 Rapikit Details
2.4.2 Rapikit Major Business
2.4.3 Rapikit Dengue Virus Diagnostic Tests Product and Solutions
2.4.4 Rapikit Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Rapikit Recent Developments and Future Plans
2.5 Wondfo
2.5.1 Wondfo Details
2.5.2 Wondfo Major Business
2.5.3 Wondfo Dengue Virus Diagnostic Tests Product and Solutions
2.5.4 Wondfo Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Wondfo Recent Developments and Future Plans
2.6 BTNX
2.6.1 BTNX Details
2.6.2 BTNX Major Business
2.6.3 BTNX Dengue Virus Diagnostic Tests Product and Solutions
2.6.4 BTNX Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 BTNX Recent Developments and Future Plans
2.7 GENESIS
2.7.1 GENESIS Details
2.7.2 GENESIS Major Business
2.7.3 GENESIS Dengue Virus Diagnostic Tests Product and Solutions
2.7.4 GENESIS Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GENESIS Recent Developments and Future Plans
2.8 Boson Biotech
2.8.1 Boson Biotech Details
2.8.2 Boson Biotech Major Business
2.8.3 Boson Biotech Dengue Virus Diagnostic Tests Product and Solutions
2.8.4 Boson Biotech Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Boson Biotech Recent Developments and Future Plans
2.9 Adaltis
2.9.1 Adaltis Details
2.9.2 Adaltis Major Business
2.9.3 Adaltis Dengue Virus Diagnostic Tests Product and Solutions
2.9.4 Adaltis Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Adaltis Recent Developments and Future Plans
2.10 AccuBio Tech
2.10.1 AccuBio Tech Details
2.10.2 AccuBio Tech Major Business
2.10.3 AccuBio Tech Dengue Virus Diagnostic Tests Product and Solutions
2.10.4 AccuBio Tech Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 AccuBio Tech Recent Developments and Future Plans
2.11 Mediven
2.11.1 Mediven Details
2.11.2 Mediven Major Business
2.11.3 Mediven Dengue Virus Diagnostic Tests Product and Solutions
2.11.4 Mediven Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Mediven Recent Developments and Future Plans
2.12 NTBIO
2.12.1 NTBIO Details
2.12.2 NTBIO Major Business
2.12.3 NTBIO Dengue Virus Diagnostic Tests Product and Solutions
2.12.4 NTBIO Dengue Virus Diagnostic Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 NTBIO Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Dengue Virus Diagnostic Tests Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Dengue Virus Diagnostic Tests Players Market Share in 2021
3.2.2 Top 10 Dengue Virus Diagnostic Tests Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Dengue Virus Diagnostic Tests Players Head Office, Products and Services Provided
3.4 Dengue Virus Diagnostic Tests Mergers & Acquisitions
3.5 Dengue Virus Diagnostic Tests New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Dengue Virus Diagnostic Tests Revenue and Market Share by Type (2017-2022)
4.2 Global Dengue Virus Diagnostic Tests Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Dengue Virus Diagnostic Tests Revenue Market Share by Application (2017-2022)
5.2 Global Dengue Virus Diagnostic Tests Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Dengue Virus Diagnostic Tests Revenue by Type (2017-2028)
6.2 North America Dengue Virus Diagnostic Tests Revenue by Application (2017-2028)
6.3 North America Dengue Virus Diagnostic Tests Market Size by Country
6.3.1 North America Dengue Virus Diagnostic Tests Revenue by Country (2017-2028)
6.3.2 United States Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
6.3.3 Canada Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
6.3.4 Mexico Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Dengue Virus Diagnostic Tests Revenue by Type (2017-2028)
7.2 Europe Dengue Virus Diagnostic Tests Revenue by Application (2017-2028)
7.3 Europe Dengue Virus Diagnostic Tests Market Size by Country
7.3.1 Europe Dengue Virus Diagnostic Tests Revenue by Country (2017-2028)
7.3.2 Germany Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
7.3.3 France Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
7.3.5 Russia Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
7.3.6 Italy Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Type (2017-2028)
8.2 Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Application (2017-2028)
8.3 Asia-Pacific Dengue Virus Diagnostic Tests Market Size by Region
8.3.1 Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Region (2017-2028)
8.3.2 China Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
8.3.3 Japan Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
8.3.4 South Korea Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
8.3.5 India Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
8.3.7 Australia Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Dengue Virus Diagnostic Tests Revenue by Type (2017-2028)
9.2 South America Dengue Virus Diagnostic Tests Revenue by Application (2017-2028)
9.3 South America Dengue Virus Diagnostic Tests Market Size by Country
9.3.1 South America Dengue Virus Diagnostic Tests Revenue by Country (2017-2028)
9.3.2 Brazil Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
9.3.3 Argentina Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Type (2017-2028)
10.2 Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Application (2017-2028)
10.3 Middle East & Africa Dengue Virus Diagnostic Tests Market Size by Country
10.3.1 Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Country (2017-2028)
10.3.2 Turkey Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
10.3.4 UAE Dengue Virus Diagnostic Tests Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Dengue Virus Diagnostic Tests Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Dengue Virus Diagnostic Tests Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Dengue Virus Diagnostic Tests Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Dengue Virus Diagnostic Tests Revenue (USD Million) by Region (2017-2022)
Table 5. Global Dengue Virus Diagnostic Tests Revenue Market Share by Region (2023-2028)
Table 6. Alere Corporate Information, Head Office, and Major Competitors
Table 7. Alere Major Business
Table 8. Alere Dengue Virus Diagnostic Tests Product and Solutions
Table 9. Alere Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Biogate Corporate Information, Head Office, and Major Competitors
Table 11. Biogate Major Business
Table 12. Biogate Dengue Virus Diagnostic Tests Product and Solutions
Table 13. Biogate Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. NovaBios Laboratories Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. NovaBios Laboratories Diagnostics Major Business
Table 16. NovaBios Laboratories Diagnostics Dengue Virus Diagnostic Tests Product and Solutions
Table 17. NovaBios Laboratories Diagnostics Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Rapikit Corporate Information, Head Office, and Major Competitors
Table 19. Rapikit Major Business
Table 20. Rapikit Dengue Virus Diagnostic Tests Product and Solutions
Table 21. Rapikit Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Wondfo Corporate Information, Head Office, and Major Competitors
Table 23. Wondfo Major Business
Table 24. Wondfo Dengue Virus Diagnostic Tests Product and Solutions
Table 25. Wondfo Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. BTNX Corporate Information, Head Office, and Major Competitors
Table 27. BTNX Major Business
Table 28. BTNX Dengue Virus Diagnostic Tests Product and Solutions
Table 29. BTNX Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GENESIS Corporate Information, Head Office, and Major Competitors
Table 31. GENESIS Major Business
Table 32. GENESIS Dengue Virus Diagnostic Tests Product and Solutions
Table 33. GENESIS Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Boson Biotech Corporate Information, Head Office, and Major Competitors
Table 35. Boson Biotech Major Business
Table 36. Boson Biotech Dengue Virus Diagnostic Tests Product and Solutions
Table 37. Boson Biotech Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Adaltis Corporate Information, Head Office, and Major Competitors
Table 39. Adaltis Major Business
Table 40. Adaltis Dengue Virus Diagnostic Tests Product and Solutions
Table 41. Adaltis Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. AccuBio Tech Corporate Information, Head Office, and Major Competitors
Table 43. AccuBio Tech Major Business
Table 44. AccuBio Tech Dengue Virus Diagnostic Tests Product and Solutions
Table 45. AccuBio Tech Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Mediven Corporate Information, Head Office, and Major Competitors
Table 47. Mediven Major Business
Table 48. Mediven Dengue Virus Diagnostic Tests Product and Solutions
Table 49. Mediven Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. NTBIO Corporate Information, Head Office, and Major Competitors
Table 51. NTBIO Major Business
Table 52. NTBIO Dengue Virus Diagnostic Tests Product and Solutions
Table 53. NTBIO Dengue Virus Diagnostic Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Dengue Virus Diagnostic Tests Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Dengue Virus Diagnostic Tests Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Dengue Virus Diagnostic Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Dengue Virus Diagnostic Tests Players Head Office, Products and Services Provided
Table 58. Dengue Virus Diagnostic Tests Mergers & Acquisitions in the Past Five Years
Table 59. Dengue Virus Diagnostic Tests New Entrants and Expansion Plans
Table 60. Global Dengue Virus Diagnostic Tests Revenue (USD Million) by Type (2017-2022)
Table 61. Global Dengue Virus Diagnostic Tests Revenue Share by Type (2017-2022)
Table 62. Global Dengue Virus Diagnostic Tests Revenue Forecast by Type (2023-2028)
Table 63. Global Dengue Virus Diagnostic Tests Revenue by Application (2017-2022)
Table 64. Global Dengue Virus Diagnostic Tests Revenue Forecast by Application (2023-2028)
Table 65. North America Dengue Virus Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Dengue Virus Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Dengue Virus Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Dengue Virus Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Dengue Virus Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Dengue Virus Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Dengue Virus Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Dengue Virus Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Dengue Virus Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Dengue Virus Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Dengue Virus Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Dengue Virus Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Dengue Virus Diagnostic Tests Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Dengue Virus Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Dengue Virus Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Dengue Virus Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Dengue Virus Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Dengue Virus Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Dengue Virus Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Dengue Virus Diagnostic Tests Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Dengue Virus Diagnostic Tests Picture
Figure 2. Global Dengue Virus Diagnostic Tests Revenue Market Share by Type in 2021
Figure 3. Dengue NS1Ag Test
Figure 4. Dengue IgG/IgM Test
Figure 5. Dengue NS1 Ag-IgG/IgM Test
Figure 6. Dengue Virus Diagnostic Tests Revenue Market Share by Application in 2021
Figure 7. Hospital Picture
Figure 8. Research Institution Picture
Figure 9. Others Picture
Figure 10. Global Dengue Virus Diagnostic Tests Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Dengue Virus Diagnostic Tests Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Dengue Virus Diagnostic Tests Revenue Market Share by Region (2017-2028)
Figure 13. Global Dengue Virus Diagnostic Tests Revenue Market Share by Region in 2021
Figure 14. North America Dengue Virus Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Dengue Virus Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Dengue Virus Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Dengue Virus Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Dengue Virus Diagnostic Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Dengue Virus Diagnostic Tests Market Drivers
Figure 20. Dengue Virus Diagnostic Tests Market Restraints
Figure 21. Dengue Virus Diagnostic Tests Market Trends
Figure 22. Alere Recent Developments and Future Plans
Figure 23. Biogate Recent Developments and Future Plans
Figure 24. NovaBios Laboratories Diagnostics Recent Developments and Future Plans
Figure 25. Rapikit Recent Developments and Future Plans
Figure 26. Wondfo Recent Developments and Future Plans
Figure 27. BTNX Recent Developments and Future Plans
Figure 28. GENESIS Recent Developments and Future Plans
Figure 29. Boson Biotech Recent Developments and Future Plans
Figure 30. Adaltis Recent Developments and Future Plans
Figure 31. AccuBio Tech Recent Developments and Future Plans
Figure 32. Mediven Recent Developments and Future Plans
Figure 33. NTBIO Recent Developments and Future Plans
Figure 34. Global Dengue Virus Diagnostic Tests Revenue Share by Players in 2021
Figure 35. Dengue Virus Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Dengue Virus Diagnostic Tests Revenue Market Share in 2021
Figure 37. Global Top 10 Players Dengue Virus Diagnostic Tests Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Dengue Virus Diagnostic Tests Revenue Share by Type in 2021
Figure 40. Global Dengue Virus Diagnostic Tests Market Share Forecast by Type (2023-2028)
Figure 41. Global Dengue Virus Diagnostic Tests Revenue Share by Application in 2021
Figure 42. Global Dengue Virus Diagnostic Tests Market Share Forecast by Application (2023-2028)
Figure 43. North America Dengue Virus Diagnostic Tests Sales Market Share by Type (2017-2028)
Figure 44. North America Dengue Virus Diagnostic Tests Sales Market Share by Application (2017-2028)
Figure 45. North America Dengue Virus Diagnostic Tests Revenue Market Share by Country (2017-2028)
Figure 46. United States Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Dengue Virus Diagnostic Tests Sales Market Share by Type (2017-2028)
Figure 50. Europe Dengue Virus Diagnostic Tests Sales Market Share by Application (2017-2028)
Figure 51. Europe Dengue Virus Diagnostic Tests Revenue Market Share by Country (2017-2028)
Figure 52. Germany Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Dengue Virus Diagnostic Tests Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Dengue Virus Diagnostic Tests Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Dengue Virus Diagnostic Tests Revenue Market Share by Region (2017-2028)
Figure 60. China Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Dengue Virus Diagnostic Tests Sales Market Share by Type (2017-2028)
Figure 67. South America Dengue Virus Diagnostic Tests Sales Market Share by Application (2017-2028)
Figure 68. South America Dengue Virus Diagnostic Tests Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Dengue Virus Diagnostic Tests Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Dengue Virus Diagnostic Tests Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Dengue Virus Diagnostic Tests Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Dengue Virus Diagnostic Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
